About Merit Medical Systems, Inc
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, fluid management, electrophysiology and cardiac rhythm management, and hemodynamic monitoring to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, swab and collection systems, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, advanced over-the-wire and direct visualization delivery systems, and dilation balloons; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. The company was incorporated in 1987 and is headquartered in South Jordan, Utah. Address: 1600 West Merit Parkway, South Jordan, UT, United States, 84095
Merit Medical Systems, Inc News and around…
Latest news about Merit Medical Systems, Inc (MMSI) common stock and company :
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Evolved US.
In trading on Monday, shares of Merit Medical Systems, Inc. (MMSI) crossed below their 200 day moving average of $64.54, changing hands as low as $64.38 per share..
SOUTH JORDAN, Utah, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it has reached an agreement in principle to settle the securities class action lawsuit against Merit and its Chief Executive Officer and Chief Financial Officer currently pe
In this article, we discuss the 15 stocks to invest in according to Kenneth Squire’s 13D Management based on Q3 holdings of the fund. If you want to skip our detailed analysis of Squire’s history, investment philosophy, and hedge fund performance, go directly to the 5 Stocks to Invest in According to Kenneth Squire’s 13D Management. […]
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Merit Medical Systems, Inc. (MMSI), where a total of 3,505 contracts have traded so far, representing approximately 350,500 underlying shares..
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Merit Medical (MMSI), in the third quarter, benefits from revenue growth in its Cardiovascular segment, and from the majority of the product categories within its Cardiovascular unit.
MMSI earnings call for the period ending September 30, 2021.
Merit Medical (MMSI) delivered earnings and revenue surprises of 18.18% and 2.36%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Q3 2021 reported revenue of $267.0 million, up 9.4% compared to Q3 2020Q3 2021 constant currency revenue, organic* up 8.8% compared to Q3 2020Q3 2021 GAAP EPS of $0.21, compared to GAAP loss per share of ($0.05) in Q3 2020Q3 2021 non-GAAP EPS* of $0.52, compared to $0.42 in Q3 2020 * Constant currency revenue; constant currency revenue, organic; core revenue; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross margin; and free cash flow are non-GAAP financial
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner ...
Companies Reporting Before The Bell • LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per ...
Is Merit Medical Systems, Inc. (NASDAQ:MMSI) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors, who employ world-class Ivy League graduates, who are given immense resources and industry contacts to put their financial expertise […]
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma ...
Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BDX vs. MMSI: Which Stock Is the Better Value Option?
Merit Medical Systems is near a possible buy point ahead of its earnings report expected around Oct. 28 .
What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...
Investors continue to be optimistic about Merit Medical (MMSI) owing to its potential in the Peripheral Intervention arm and a strong product portfolio.
SOUTH JORDAN, Utah, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the quarter ended September 30, 2021, after the close of the stock market on Thursday, October 28, 2021. Merit will hold its inv
PDCO vs. MMSI: Which Stock Is the Better Value Option?
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Comtech Telecommunications Corp. (CMTL), where a total of 4,137 contracts have traded so far, representing approximately 413,700 underlying shares..
Backed by robust long-term prospects, investors can add three lucrative MedTech stocks, MMSI, ITGR and OFIX, to their watchlist.
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in International Game Technology PLC (IGT), where a total of 17,401 contracts have traded so far, representing approximately 1.7 million underlying shares. That amounts to about 104% of IGT's average daily trading volume over the past month of 1.7 million shares..
Presentation Times and Weblinks Released for Over 130 Presenting CompaniesWednesday and Thursday, September 22 - 23, 2021NEW YORK, NY / ACCESSWIRE / September 21, 2021 / Sidoti & Company, LLC proudly releases the presentation schedule, with weblink click-throughs, for its Sidoti Fall Virtual Small Cap Investor Conference, to be held on Wednesday, September 22, 2021, and Thursday, September 23, 2021. Virtual Agenda - Wednesday, September 22nd - All Times EDT Click on Company Name to Open Link to
Brian G Lloyd, Chief Legal Officer And Secretary at Merit Medical Systems (NASDAQ:MMSI), made a large buy and sell of company shares on September 15, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission reports that on September 15, Brian G Lloyd bought 20,000 Merit Medical Systems shares at a price of $28.20 per share, for a total of $564,000. They then sold their shares on succeeding transactions in the open market at prices ranging fro
The Zacks Analyst Blog Highlights: Align Technology, West Pharmaceutical Services, Henry Schein and Merit Medical Systems
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Merit Medical Systems, Inc (MMSI) is a NASDAQ Common Stock listed in Common Stock, Healthcare, Medical Instruments & Supplies
